Accelerate Diagnostics Inc – Strategy, SWOT and Corporate Finance Report

Accelerate Diagnostics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentations for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients suspected of bacteremia or fungemia. Accelerate uses its proprietary molecular identification methods and morphokinetic cellular analysis to provide quantitative ID/AST results. The company has a manufacturing facility in Tucson Arizona. It sells products to hospital microbiology laboratories through a direct sales force. Accelerate is headquartered in Tucson, Arizona, the US.

Scope

Detailed information on Accelerate Diagnostics Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Accelerate Diagnostics Inc in the form of a SWOT analysis

An in-depth view of the business model of Accelerate Diagnostics Inc including a breakdown and examination of key business segments

News about Accelerate Diagnostics Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Accelerate Diagnostics Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Accelerate Diagnostics Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Accelerate Diagnostics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

T2 Biosystems Inc

Luminex Corp

Danaher Corp

Bruker Corp

bioMerieux SA

Becton Dickinson and Co

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Accelerate Diagnostics Inc - Key Facts

Accelerate Diagnostics Inc - Key Employees

Accelerate Diagnostics Inc - Key Employee Biographies

Accelerate Diagnostics Inc - Major Products and Services

Accelerate Diagnostics Inc - History

Accelerate Diagnostics Inc - Company Statement

Accelerate Diagnostics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Accelerate Diagnostics Inc - Business Description

R&D Overview

Accelerate Diagnostics Inc - SWOT Analysis

SWOT Analysis - Overview

Accelerate Diagnostics Inc - Strengths

Accelerate Diagnostics Inc - Weaknesses

Accelerate Diagnostics Inc - Opportunities

Accelerate Diagnostics Inc - Threats

Accelerate Diagnostics Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Accelerate Diagnostics Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

May 09, 2019: Accelerate Diagnostics reports first quarter 2019 financial results

Feb 19, 2019: Accelerate Diagnostics reports 2018 fourth quarter and full-year financial results

Jan 06, 2019: Accelerate Diagnostics announces preliminary 2018 fourth quarter and full-year financial results

Nov 06, 2018: Accelerate Diagnostics reports Q3 2018 financial results

Sep 27, 2018: Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa

Aug 06, 2018: Accelerate Diagnostics reports Q2 2018 financial results

May 09, 2018: Accelerate Diagnostics reports Q1 2018 financial results

Feb 15, 2018: Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Accelerate Diagnostics Inc, Key Facts

Accelerate Diagnostics Inc, Key Employees

Accelerate Diagnostics Inc, Key Employee Biographies

Accelerate Diagnostics Inc, Major Products and Services

Accelerate Diagnostics Inc, History

Accelerate Diagnostics Inc, Subsidiaries

Accelerate Diagnostics Inc, Key Competitors

Accelerate Diagnostics Inc, Ratios based on current share price

Accelerate Diagnostics Inc, Annual Ratios

Accelerate Diagnostics Inc, Annual Ratios (Cont…1)

Accelerate Diagnostics Inc, Interim Ratios

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Accelerate Diagnostics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Accelerate Diagnostics Inc, Performance Chart (2014 – 2018)

Accelerate Diagnostics Inc, Ratio Charts

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports